| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| February 6, 2026 | ±4.8% | +3.4% | over-priced |
| November 6, 2025 | ±2.1% | +6.9% | under-priced |
| August 7, 2025 | ±1.8% | +6.8% | under-priced |
| February 7, 2025 | ±2.7% | -1.0% | over-priced |
| November 7, 2024 | ±2.5% | -5.3% | under-priced |
| August 8, 2024 | ±3.8% | +2.6% | over-priced |
| February 8, 2024 | ±2.3% | -2.5% | under-priced |
| November 7, 2023 | ±1.6% | +0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | $2.24 | $1.6B | $220M |
| Q3 FY2026 | $1.96 | $1.5B | $194M |
| Q2 FY2026 | $1.94 | $1.5B | $193M |
| Q1 FY2026 | $1.79 | $1.4B | $178M |
STERIS plc (STE) reports in 53 days, with the next report estimated for August 5, 2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 3.6% on average — the market has been roughly fair on STE's earnings risk. Fundamentals into the print: EPS up 52.4% year-over-year, revenue up 7.3%. QuantLogix's live 5-factor engine currently reads STE as a neutral at 42/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →